03/26/2025
6:11 PM | BML Investment Partners, L.P. (Filed by)
Elevation Oncology (Subject)
| Form SCHEDULE 13G | |
03/20/2025
7:08 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2025
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
3:52 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
12:34 PM | Elevation Oncology (Subject)
Logos Global Management LP (Filed by)
| Form SCHEDULE 13G/A | |
02/06/2025
1:52 PM | Elevation Oncology (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
8:33 PM | Elevation Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/13/2025
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
3:15 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:50 PM | Elevation Oncology (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
Get the Latest News and Ratings for ELEV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
6:05 PM | Elevation Oncology (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G/A | |
11/14/2024
5:45 PM | Elevation Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
3:28 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Elevation Oncology (Subject)
| Form SC 13G/A | |
11/12/2024
1:22 PM | Elevation Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
10:54 AM | Elevation Oncology (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
11/06/2024
1:40 PM | Elevation Oncology (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G | |
11/06/2024
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:00 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
10:49 AM | Elevation Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/09/2024
8:01 AM | Elevation Oncology (Subject)
Empery Asset Management, LP (Filed by)
| Form SC 13G/A | |
09/18/2024
3:15 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:15 PM | Elevation Oncology (Issuer)
Furlong Tammy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:05 PM | Elevation Oncology (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
| Form SC 13D/A | |
08/06/2024
6:30 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:45 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024
12:17 PM | Elevation Oncology (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SC 13G/A | |
06/17/2024
3:26 PM | Elevation Oncology (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:28 PM | Elevation Oncology (Issuer)
Mootz Darcy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:30 PM | Elevation Oncology (Issuer)
Sandler Alan B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
11:15 PM | Elevation Oncology (Filer)
| Form EFFECT | |
05/02/2024
7:01 AM | Elevation Oncology (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/02/2024
6:47 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:01 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:25 PM | Elevation Oncology (Filer)
| Form ARS | |
04/26/2024
3:20 PM | Elevation Oncology (Filer)
| Form DEFA14A | |
04/26/2024
3:15 PM | Elevation Oncology (Filer)
| Form DEF 14A | |
04/09/2024
3:26 PM | Elevation Oncology (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SC 13G | |
04/05/2024
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy ELEV Stock Free ELEV Stock Alerts